CPEB1 and endothelial dysfunction: miR-129-3p has been reported to implicate in breast cancer cell apoptosis [12], and CPEB1 inhibition could suppress oxidative stress, inflammation, and apoptosis in oxidized low-density lipoprotein–induced endothelial dysfunction [23].